On the contrary, administration of recombinant human TRAIL improved metabolic abnormalities and alleviated NAFLD in high-fat diet (HFD)-fed mice [35]. The gene discussed is TNFSF10; the disease is metabolic dysfunction-associated steatotic liver disease.